Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Microsaic Wins R&D100 Award

25 Jun 2012 10:29

RNS Number : 0480G
Microsaic Systems plc
25 June 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Microsaic Systems Wins R&D 100 Award for the World's Most Compact Mass Spectrometer

 

25 June 2012

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is proud to announce that its 3500 MiD mass spectrometer has been chosen as an R&D 100 award winner by an independent judging panel and the editors of R&D Magazine. The award recognises the 3500 MiD as one of the most technologically significant products to enter the marketplace in 2011. Microsaic is the first and only company to have commercialised MS (mass spectrometry) technology on a chip. The instrument distinguished itself among other entries as the chips allow production of MS detectors that are smaller, lighter, consume less energy, are easier to maintain and cheaper to run than conventional MS systems.

 

MS is widely accepted as one of the most reliable methods for identifying chemicals, and MS systems are used to accurately identify the chemicals that make up gaseous, liquid and solid samples. MS is used across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food & drink, healthcare and industrial chemicals. Although fast and sensitive, typical MS systems are large, heavy, energy intensive, expensive and complex to use; as a result, MS systems tend to be shared, central facilities. The 3500 MiD represents a step change in the ease of use and footprint of mass spectrometry.

 

Most revolutionary is the fact that the 3500 MiD, is fully self-contained, making it highly portable. Other commercial mass spectrometers have external vacuum pumps, which typically sit on the floor and connect to the instrument with vacuum hoses. The 3500 MiD's small size - about one third that of the main unit of typical competitors - means it can be easily incorporated within a stack or cluster of instruments on a particular chemist's work space, and is also small enough to sit inside a fume hood. This results in greater workplace productivity, by giving chemists access to immediate results, offering economic benefit in areas such as drug discovery and synthesis. It will also bring the accuracy and reliability of mass spectrometry to on-site analysis applications such as sports forensics, food & beverage quality, and oil and gas exploration.

 

"The awards have long been a benchmark of excellence so we are delighted to have been selected for the R&D 100 award - the competition has been strong this year so it is a great achievement to be acknowledged by industry leaders as one of the most valuable and significant products released to the market," said Professor Eric Yeatman, CEO of Microsaic Systems. "The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection. Its low purchase, operating cost and small footprint, make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach until now - a true innovation."

 

 

Enquiries:

 

Microsaic Systems plc

Eric Yeatman, CEO

via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

+44 (0)20 7260 1000

Citigate Dewe Rogerson (Financial PR)

Chris Gardner, Mark Swallow, Malcolm Robertson

+44 (0)20 7638 9571

The Scott Partnership (Trade PR)

Sarah Evans

+44 (0)1477 539540

About Microsaic Systems plc

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFFARDIEFIF
Date   Source Headline
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSHalf-year Report
26th Aug 20161:15 pmRNSProposed Placing of New Shares
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.